CCL3 and Alzheimer disease: Its deficiency can independently activate the Akt and NFAT1 pathways, driving pro-inflammatory microglial activity characterized by the release of TNF-α and Chemokine (C-C motif) ligand 3 (CCL3), thereby contributing to AD independently from the NF-κB pathway [25].